488 related articles for article (PubMed ID: 9222597)
1. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein.
Brown CR; Hong-Brown LQ; Biwersi J; Verkman AS; Welch WJ
Cell Stress Chaperones; 1996 Jun; 1(2):117-25. PubMed ID: 9222597
[TBL] [Abstract][Full Text] [Related]
2. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
3. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
French PJ; van Doorninck JH; Peters RH; Verbeek E; Ameen NA; Marino CR; de Jonge HR; Bijman J; Scholte BJ
J Clin Invest; 1996 Sep; 98(6):1304-12. PubMed ID: 8823295
[TBL] [Abstract][Full Text] [Related]
4. Strategies for correcting the delta F508 CFTR protein-folding defect.
Brown CR; Hong-Brown LQ; Welch WJ
J Bioenerg Biomembr; 1997 Oct; 29(5):491-502. PubMed ID: 9511934
[TBL] [Abstract][Full Text] [Related]
5. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.
Denning GM; Anderson MP; Amara JF; Marshall J; Smith AE; Welsh MJ
Nature; 1992 Aug; 358(6389):761-4. PubMed ID: 1380673
[TBL] [Abstract][Full Text] [Related]
6. Organic solutes rescue the functional defect in delta F508 cystic fibrosis transmembrane conductance regulator.
Zhang XM; Wang XT; Yue H; Leung SW; Thibodeau PH; Thomas PJ; Guggino SE
J Biol Chem; 2003 Dec; 278(51):51232-42. PubMed ID: 14532265
[TBL] [Abstract][Full Text] [Related]
7. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation.
Sato S; Ward CL; Krouse ME; Wine JJ; Kopito RR
J Biol Chem; 1996 Jan; 271(2):635-8. PubMed ID: 8557666
[TBL] [Abstract][Full Text] [Related]
8. Functional activation of the cystic fibrosis trafficking mutant delta F508-CFTR by overexpression.
Cheng SH; Fang SL; Zabner J; Marshall J; Piraino S; Schiavi SC; Jefferson DM; Welsh MJ; Smith AE
Am J Physiol; 1995 Apr; 268(4 Pt 1):L615-24. PubMed ID: 7733303
[TBL] [Abstract][Full Text] [Related]
9. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.
Rubenstein RC; Egan ME; Zeitlin PL
J Clin Invest; 1997 Nov; 100(10):2457-65. PubMed ID: 9366560
[TBL] [Abstract][Full Text] [Related]
10. Chaperones rescue the energetic landscape of mutant CFTR at single molecule and in cell.
Bagdany M; Veit G; Fukuda R; Avramescu RG; Okiyoneda T; Baaklini I; Singh J; Sovak G; Xu H; Apaja PM; Sattin S; Beitel LK; Roldan A; Colombo G; Balch W; Young JC; Lukacs GL
Nat Commun; 2017 Aug; 8(1):398. PubMed ID: 28855508
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTR delta F508.
Paddon C; Loayza D; Vangelista L; Solari R; Michaelis S
Mol Microbiol; 1996 Mar; 19(5):1007-17. PubMed ID: 8830258
[TBL] [Abstract][Full Text] [Related]
12. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.
Guay-Broder C; Jacobson KA; Barnoy S; Cabantchik ZI; Guggino WB; Zeitlin PL; Turner RJ; Vergara L; Eidelman O; Pollard HB
Biochemistry; 1995 Jul; 34(28):9079-87. PubMed ID: 7542476
[TBL] [Abstract][Full Text] [Related]
13. Mutation of R555 in CFTR-delta F508 enhances function and partially corrects defective processing.
Teem JL; Carson MR; Welsh MJ
Recept Channels; 1996; 4(1):63-72. PubMed ID: 8723647
[TBL] [Abstract][Full Text] [Related]
14. Mammalian osmolytes and S-nitrosoglutathione promote Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) protein maturation and function.
Howard M; Fischer H; Roux J; Santos BC; Gullans SR; Yancey PH; Welch WJ
J Biol Chem; 2003 Sep; 278(37):35159-67. PubMed ID: 12837761
[TBL] [Abstract][Full Text] [Related]
15. ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
Pankow S; Bamberger C; Calzolari D; Martínez-Bartolomé S; Lavallée-Adam M; Balch WE; Yates JR
Nature; 2015 Dec; 528(7583):510-6. PubMed ID: 26618866
[TBL] [Abstract][Full Text] [Related]
16. Nanomolar affinity small molecule correctors of defective Delta F508-CFTR chloride channel gating.
Yang H; Shelat AA; Guy RK; Gopinath VS; Ma T; Du K; Lukacs GL; Taddei A; Folli C; Pedemonte N; Galietta LJ; Verkman AS
J Biol Chem; 2003 Sep; 278(37):35079-85. PubMed ID: 12832418
[TBL] [Abstract][Full Text] [Related]
17. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
19. Modulation of deltaF508 cystic fibrosis transmembrane regulator trafficking and function with 4-phenylbutyrate and flavonoids.
Lim M; McKenzie K; Floyd AD; Kwon E; Zeitlin PL
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):351-7. PubMed ID: 15191910
[TBL] [Abstract][Full Text] [Related]
20. Mutant (delta F508) cystic fibrosis transmembrane conductance regulator Cl- channel is functional when retained in endoplasmic reticulum of mammalian cells.
Pasyk EA; Foskett JK
J Biol Chem; 1995 May; 270(21):12347-50. PubMed ID: 7539001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
